Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll‐like receptor 4

S Fineschi, L Goffin, R Rezzonico… - … : Official Journal of …, 2008 - Wiley Online Library
Objective Previous studies have revealed the presence of IgG antifibroblast antibodies
(AFAs) capable of binding to the surface of fibroblasts in systemic sclerosis (SSc) sera. Since …

The CC chemokine ligand 2 (CCL2) mediates fibroblast survival through IL-6

X Liu, AM Das, J Seideman, D Griswold… - American journal of …, 2007 - atsjournals.org
Apoptosis of lung structural cells is crucial in the process of normal tissue repair. Insufficient
apoptosis of lung fibroblasts may contribute to the development of fibrosis. Since the CC …

[HTML][HTML] Dark side of cancer therapy: cancer treatment-induced cardiopulmonary inflammation, fibrosis, and immune modulation

E Boopathi, C Thangavel - International Journal of Molecular Sciences, 2021 - mdpi.com
Advancements in cancer therapy increased the cancer free survival rates and reduced the
malignant related deaths. Therapeutic options for patients with thoracic cancers include …

TGF-β1 stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent process

J Cheng, MMD Encarnacion… - … of Physiology-Cell …, 2005 - journals.physiology.org
Monocyte chemoattractant protein-1 (MCP-1) and transforming growth factor (TGF)-β1 are
critical mediators of renal injury by promoting excessive inflammation and extracellular …

[HTML][HTML] Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage

O Garcia, G Carraro, G Turcatel, M Hall, S Sedrakyan… - PloS one, 2013 - journals.plos.org
The potential for amniotic fluid stem cell (AFSC) treatment to inhibit the progression of fibrotic
lung injury has not been described. We have previously demonstrated that AFSC can …

[HTML][HTML] The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: a review

B Zhou, H Liu, F Xu, X Jia - Cell Communication and Signaling, 2024 - Springer
Pulmonary fibrosis (PF) is a progressive interstitial inflammatory disease with a high
mortality rate. Patients with PF commonly experience a chronic dry cough and progressive …

Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis

RC Russo, AL Alessandri, CC Garcia… - American Journal of …, 2011 - atsjournals.org
CC chemokines play an important role in the pathogenesis of idiopathic pulmonary fibrosis.
Few studies have evaluated the efficacy of therapeutically targeting CC chemokines and …

Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice

RC Russo, CC Garcia, LS Barcelos… - Journal of leukocyte …, 2011 - academic.oup.com
ABSTRACT PI3Kγ is central in signaling diverse arrays of cellular functions and
inflammation. Pulmonary fibrosis is associated with pulmonary inflammation, angiogenesis …

Animal models of pulmonary fibrosis

M Gharaee-Kermani, M Ullenbruch… - … Research: Methods and …, 2005 - Springer
In general, there are two types of animal models: natural and experimental. Because there
are no natural models for pulmonary fibrosis, an experimental model that reproduces key …

The atypical chemokine receptor ACKR2 drives pulmonary fibrosis by tuning influx of CCR2+ and CCR5+ IFNγ-producing γδT cells in mice

RC Russo, B Savino, M Mirolo… - … of Physiology-Lung …, 2018 - journals.physiology.org
Chemokines coordinate lung inflammation and fibrosis by acting on chemokine receptors
expressed on leukocytes and other cell types. Atypical chemokine receptors (ACKRs) bind …